Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

NCT04847063 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

NIH

Sponsor class

Conditions

Peritoneal Mesothelioma
Peritoneal Carcinomatosis
Ovarian Cancer
Gastrointestinal Cancer
Appendiceal Cancer
Atypical Mesothelial Proliferation
Colorectal Cancer

Interventions

DRUG: Sodium Thiosulfate
DRUG: 5-Fluorouracil
DRUG: Oxaliplatin
DRUG: Doxorubicin
PROCEDURE: Hyperthermic Intraperitonial Chemotherapy
DRUG: Cisplatin
DRUG: Mitomycin C

Sponsor

National Cancer Institute (NCI)